Long COVID "brain fog" shares features with "chemo brain"


By Reuters Staff

(Reuters) - The "brain fog" reported by some people after COVID-19 shows striking similarities to the condition known as "chemo brain" - the mental cloudiness some people experience during and after cancer treatment, according to new research.

People who had COVID-19 "frequently experience lingering neurological symptoms, including impairment in attention, concentration, speed of information processing and memory," similar to patients with cancer therapy-related cognitive impairment that is known to involve inflammation of the brain, the researchers explained in a report posted on bioRxiv ahead of peer review.

In the brains of patients who died of COVID-19, the researchers found evidence of inflammation along with high levels of inflammatory proteins, one of which, CCL11, is linked with impairments in nervous system health and cognitive function.

Among 63 patients with so-called long COVID, the researchers found high CCL11 levels in the 48 with lingering cognitive symptoms, but not in the 15 without cognitive issues. They speculate that treatments showing promise for cancer therapy-related cognitive impairment might be helpful for COVID-19 patients with similar problems. But they would need to be tested specifically for long COVID.

SOURCE: https://bit.ly/3zQVN8i bioRxiv, online January 10, 2022.

Related Articles

Healthy lifestyle interventions may be best started in preschool

By Linda Carroll (Reuters Health) - Implementing school-based programs aimed at teaching healthy cardiovascular habits starting in preschool can achieve lasting lifestyle changes in children, Read More »

Canada approves Pfizer's oral COVID-19 antiviral treatment, seeks supplies

By David Ljunggren and Ismail Shakil OTTAWA (Reuters) - Canada on Monday approved Pfizer Inc's oral antiviral treatment for mild to moderate cases of COVID-19 in people aged 18 and older but said Read More »

Secondhand vaping linked with respiratory symptoms in young adults

By Linda Carroll (Reuters Health) - Exposure to secondhand vape at home may be linked to a heightened risk for respiratory symptoms in young adults, a new study suggests. An analysis of data from Read More »